HEMANGIOL 3.75 mg/mL oral solution

DRUG2 trials

Sponsors

Centre Hospitalier Regional De Marseille, Radboud universitair medisch centrum Stichting

Conditions

Children and teenagers with refractory/relapsing solid tumorReactive aggression

Phase 1

Phase 1 study of a Propranolol (HEMANGIOL®) and oral metronomic Vinorelbine (NAVELBINE®) combination on children and teenagers With Refractory/Relapsing Solid Tumors - PROVIN

RecruitingCTIS2024-517185-42-00

Centre Hospitalier Regional De MarseilleChildren and teenagers with refractory/relapsing solid tumor

Start: 2020-05-04Target: 58Updated: 2025-09-09

Phase 2

Propranolol Dosefinding Assessment in Reactive Aggression Treatment (PRO-DART)

Not yet recruitingCTIS2026-526545-95-00

Radboud universitair medisch centrum StichtingReactive aggression

Target: 30Updated: 2026-09-02